These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16 related articles for article (PubMed ID: 10243270)
1. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations. Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564 [No Abstract] [Full Text] [Related]
2. Maximum allowable cost: can the government control drug costs? Smith MI; Wertheimer AI J Health Polit Policy Law; 1979; 4(2):155-75. PubMed ID: 385712 [TBL] [Abstract][Full Text] [Related]
3. The MAC program and advisors to the government. Shubin S Hosp Formul; 1981 Aug; 16(8):869-72, 877-9. PubMed ID: 10252371 [No Abstract] [Full Text] [Related]
5. The Maximum Allowable Cost program--some marketing consequences. Gosselin RA Med Mark Media; 1978 Feb; 13(2):19-20, 22, 24 passim. PubMed ID: 10306394 [No Abstract] [Full Text] [Related]
6. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy. Paul SH Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270 [No Abstract] [Full Text] [Related]
7. A comparative study of European rare disease and orphan drug markets. Denis A; Mergaert L; Fostier C; Cleemput I; Simoens S Health Policy; 2010 Oct; 97(2-3):173-9. PubMed ID: 20800761 [TBL] [Abstract][Full Text] [Related]